Adaptation of ghrelin and the GH/IGF axis to high altitude

European Journal of Endocrinology

Volumn 166, Issue 6, 2012, Pages 969-976

  Riedl, Stefan ^a   Kluge, Michael ^b   Schweitzer, Katharina ^a   Waldhör, Thomas ^a   Frisch, Herwig ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACID LABILE SUBUNIT; CHEMICAL COMPOUND; GHRELIN; GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; INSULIN; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ADULT; ALTITUDE ACCLIMATIZATION; ARTICLE; BIOAVAILABILITY; BODY MASS; CONTROLLED STUDY; ENERGY BALANCE; ENVIRONMENTAL EXPOSURE; FEMALE; GROWTH HORMONE RELEASE; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; IMMUNOREACTIVITY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SCORING SYSTEM; UPREGULATION; WEIGHT REDUCTION; WELLBEING;

ACCLIMATIZATION; ADULT; ALTITUDE; ALTITUDE SICKNESS; BODY WEIGHT; CARRIER PROTEINS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GHRELIN; GLYCOPROTEINS; HUMAN GROWTH HORMONE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGED; SOMATOMEDINS; TIME FACTORS;

EID: 84862741560     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0007     Document Type: Article

References (40)

1. Gil-Campos M, Aguilera CM, Cañete R & Gil A. Ghrelin: a hormone regulating food intake and energy homeostasis. British Journal of Nutrition 2006 96 201-226. (doi:10.1079/BJN20061787)
2. Klok MD, Jakobsdottir S & Drent ML. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obesity Reviews 2007 8 21-34. (doi:10.1111/j.1467-789X.2006.00270.x)
3. Kamegai J, Tamura H, Shimizu T, Ishii S, Tatsuguchi A, Sugihara H, Oikawa S & Kineman RD. The role of pituitary ghrelin in growth hormone (GH) secretion: GH-releasing hormone-dependent regulation of pituitary ghrelin gene expression and peptide content. Endocrinology 2004 145 3731-3738. (doi:10.1210/en.2003-1424)
4. Nass R, Farhy LS, Liu J, Prudom CE, Johnson ML, Veldhuis P, Pezzoli SS, Oliveri MC, Gaylinn BD, Geysen HM & Thorner MO. Evidence for acyl-ghrelin modulation of growth hormone release in the fed state. Journal of Clinical Endocrinology and Metabolism 2008 93 1988-1994. (doi:10.1210/jc.2007-2234)
5. Nguyen UN, Mougin F, Simon-Rigaud ML, Rouillon JD, Marguet P & Regnard J. Influence of exercise duration on serum insulin-like growth factor and its binding proteins in athletes. European Journal of Applied Physiology 1998 78 533-537. (doi:10.1007/s004210050456)
6. Koziris LP, Hickson RC, Chatterton RT, Groseth RT, Christie JM, Goldflies DG & Unterman TG. Serum levels of total and free IGF-I and IGFBP-3 are increased and maintained in long-term training. Journal of Applied Physiology 1999 86 1436-1442. (Pubitemid 29172182)
7. Brown J, Jones EY & Forbes BE. Keeping IGF-II under control: lessons from the IGF-II-IGF2R crystal structure. Trends in Biochemical Sciences 2009 34 612-619. (doi:10.1016/j.tibs.2009.07.003)
8. Holt RIG, Simpson HL & Sönksen PH. The role of the growth hormone-insulin-like growth factor axis in glucose homeostasis. Diabetic Medicine 2003 20 3-15. (doi:10.1046/j.1464-5491.2003.00827.x)
9. Wheatcroft SB & Kearney MT. IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis. Trends in Endocrinology and Metabolism 2009 20 153-162. (doi:10.1016/j.tem.2009.01. 002)
10. Popovici RM, Lu M, Bhatia S, Faessen GH, Giaccia AJ & Giudice LC. Hypoxia regulates insulin-like growth factor-binding protein 1 in human fetal hepatocytes in primary culture: suggestive molecular mechanisms for in utero fetal growth restriction caused by uteroplacental insufficiency. Journal of Clinical Endocrinology and Metabolism 2001 86 2653-2659. (doi:10.1210/jc.86.6. 2653)
11. HamadN&Travis SPL.Weight loss athigh altitude: pathophysiology and practical implications. European Journal of Gastroenterology & Hepatology 2006 18 5-10. (doi:10.1097/00042737-200601000-00002)
12. Shukla V, Singh SN, Vats P, Singh VK, Singh SB & Banerjee PK. Ghrelin and leptin levels of sojourners and acclimatized lowlanders at high altitude. Nutritional Neuroscience 2005 8 161-165. (doi:10.1080/10284150500132823)
13. Benso A, Broglio F, Aimaretti G, Lucatello B, Lanfranco F, Ghigo E & Grottoli S. Endocrine and metabolic responses to extreme altitude and physical exercise in climbers. European Journal of Endocrinology 2007 157 733-740. (doi:10.1530/EJE-07-0355)
14. Frisch H, Waldhauser F, Waldhör T, Müllner-Eidenböck A, Neupane P & Schweitzer K. Increase in 6-hydroxymelatonin excretion in humans during ascent to high altitude. Journal of Clinical Endocrinology and Metabolism 2004 89 4388-4390. (doi:10.1210/jc.2003-032214)
15. Haditsch B, Roessler A & Hinghofer-Szalkay HG. Renal adrenomedullin and high altitude diuresis. Physiological Research 2007 56 779-787.
16. Feddersen B, Ausserer H, Neupane P, Thanbichler F, Depaulis A, Waanders R & Noachtar S. Right temporal cerebral dysfunction heralds symptoms of acute mountain sickness. Journal of Neurology 2007 254 359-363. (doi:10.1007/s00415- 006-0376-8)
17. Roach RC, Bartsch P, Oelz O & Hackett PH & the Lake Louise AMS Scoring Consensus Committee. The Lake Louise acute mountain sickness scoring system. In Hypoxia and Molecular Medicine, pp 272-274. Eds JR Sutton, CS Houston & G Coates, Burlington, VT: Charles S. Houston, 1993.
18. Blum WF, Cotterill AM, Postel-Vinay MC, Ranke MB, Savage MO & Wilton P. Improvement of diagnostic criteria in growth hormone insensitivity syndrome: solutions and pitfalls. Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes. Acta Paediatrica Supplement 1994 399 117-124. (doi:10.1111/j.1651-2227.1994.tb13303.x)
19. Blum WF & Breier BH. Radioimmunoassays for IGFs and IGFBPs. Growth Regulation 1994 4 (Suppl 1) 11-19.
20. Natalucci G, Riedl S, Gleiss A, Zidek T & Frisch H. Spontaneous 24-hour ghrelin secretion pattern in fasting subjects: maintenance of a meal-related pattern. European Journal of Endocrinology 2005 152 845-850. (doi:10.1530/eje.1.01919)
21. Kleinz MJ, Maguire JJ, Skepper JN & Davenport AP. Functional and immunocytochemical evidence for a role of ghrelin and des-octanoyl ghrelin in the regulation of vascular tone in man. Cardiovascular Research 2006 69 227-235. (doi:10.1016/j.cardiores.2005.09.001)
22. Schwenke DO, Tokudome T, Shirai M, Hosoda H, Horio T, Kishimoto I & Kangawa K. Exogenous ghrelin attenuates the progression of chronic hypoxia-induced pulmonary hypertension in conscious rats. Endocrinology 2008 149 237-244. (doi:10.1210/en.2007-0833)
23. Schwenke DO, Tokudome T, Kishimoto I, Horio T, Shirai M, Cragg PA & Kangawa K. Early ghrelin treatment following myocardial infarction prevents an increase in cardiac sympathetic tone and reduces mortality. Endocrinology 2008 149 5172-5176. (doi:10.1210/en.2008-0472)
24. Lippl FJ, Neubauer S, Schipfer S, Lichter N, Tufman A, Otto B & Fischer R. Hypobaric hypoxia causes body weight reduction in obese subjects. Obesity 2010 18 675-681. (doi:10.1038/oby.2009.509)
25. Banfi G, Marinelli M, Roi GS, Columbini A, Potillo M, Giacometti M & Wade S. Growth hormone and insulin-like growth factor I in athletes performing a marathon at 4000 m of altitude. Growth Regulation 1994 4 82-86. (Pubitemid 24229897)
26. Ramirez G, Herrerat R, Pineda D, Bittle P, Rabb H & Bercus B. The effects of high altitude on hypothalamic-pituitary secretory dynamics in men. Clinical Endocrinology 1995 43 11-18. (doi:10.1111/j.1365-2265.1995.tb01887.x)
27. Schmidt W, Dore S, Hilgendorf A, Strauch S, Gareau R & Brisson GR. Effects of exercise during normoxia and hypoxia on the growth hormone-insulin-like growth factor I axis. European Journal of Applied Physiology 1995 71 424-430. (doi:10.1007/BF00635876)
28. Greenman Y, Golani N, Gilad S, Yaron M, Limor R & Stern N. Ghrelin secretion is modulated in a nutrient and gender specific manner. Clinical Endocrinology 2004 60 382-388. (doi:10.1111/j.1365-2265.2004.01993.x)
29. Frystyk J, Andreasen CM & Fisker S. Determination of free growth hormone. Journal of Clinical Endocrinology and Metabolism 2008 93 3008-3014. (doi:10.1210/jc.2008-0375)
30. Tapanainen PJ, Bang P, Wilson K, Unterman TG, Vreman HJ & Rosenfeld RG. Maternal hypoxia as a model for intrauterine growth retardation: effects on insulin-like growth factors and their binding proteins. Pediatric Research 1994 36 152-158. (doi:10.1203/00006450-199408000-00004)
31. Verhaeghe J, van Herck E, Billen J, Moerman P, van Assche FA & Giudice LC. Regulation of insulin-like growth factor-I and Insulin-like growth factor binding protein-1 concentration in preterm fetuses. American Journal of Obstetrics and Gynecology 2003 188 485-491. (doi:10.1067/mob.2003.26)
32. Street ME, Seghini P, Fieni S, Ziveri MA, Volta C, Martorana D, Viani I, Gramellini D & Bernasconi S. Changes in interleukin-6 and IGF system and their relationships in placenta and cord blood in newborns with fetal growth restriction compared with controls. European Journal of Endocrinology 2006 155 567-574. (doi:10.1530/eje.1.02251)
33. Bang AS, Soule SG, Yandle TG, Richards AM & Pemberton CJ. Characterisation of proghrelin in mammalian tissue and plasma. Journal of Endocrinology 2007 192 313-323. (doi:10.1677/JOE-06-0021)
34. Mortola JP. Hypoxia and circadian patterns. Respiratory Physiology & Neurobiology 2007 158 274-279. (doi:10.1016/j.resp.2007.02.005)
35. Johnson PL, Edwards N, Burgess KR & Sullivan CE. Sleep architecture changes during a trek from 1400 to 5000 m in the Nepal Himalaya. Journal of Sleep Research 2010 19 148-156. (doi:10.1111/j.1365-2869.2009.00745.x)
36. Arendt J. Importance and relevance of melatonin to human biological rhythms. Journal of Neuroendocrinology 2003 15 427-431. (doi:10.1046/j.1365- 2826.2003.00987.x)
37. Tschöp M, Strasburger CJ, Hartmann G, Biollaz J & Bärtsch P. Raised leptin concentrations at high altitude associated with loss of appetite. Lancet 1998 352 1119-1120. (doi:10.1016/S0140-6736(05)79760-9)
38. Zaccaria M, Ermolao A, Bonvicini P, Travain G & Varnier M. Decreased serum leptin levels during prolonged high altitude exposure. European Journal of Applied Physiology 2004 92 249-253. (doi:10.1007/s00421-004-1070-0)
39. Barnholt KE, Hoffman AR, Rock PB, Muza SR, Fulco CS, Braun B, Holloway L, Mazzeo RS, Cymerman A & Friedlander AL. Endocrine responses to acute and chronic high-altitude exposure (4,300 meters): modulating effects of caloric restriction. American Journal of Physiology. Endocrinology and Metabolism 2006 290 E1078-E1088. (doi:10.1152/ajpendo.00449.2005)
40. Grosfeld A, Zilberfarb V, Turban S, André J, Guerre-Millo M & Issad T. Hypoxia increases leptin expression in human PAZ6 adipose cells. Diabetologia 2002 45 527-530. (doi:10.1007/s00125-002-0804-y)